So, Capivasertib is this AKT inhibitor that’s used specifically for HR /HER2-positive breast cancer. It zeroes in on those PIK3CA, AKT1, and PTEN alterations and puts the brakes on AKT signaling. You’re looking at 400 mg pills, and they come in packets of 64.
The deal is to take 400 mg twice a day for four days, then you’ve got three days off. And that cycle keeps going.
Reviews
There are no reviews yet.